The high bone mass gene of 11q13.3

Details for Australian Patent Application No. 2007200352 (hide)

Owner Creighton University Oscient Pharmaceuticals Corporation

Inventors Not Given

Agent Blake Dawson Waldron Patent Services

Pub. Number AU-A-2007200352

Parent 2000256269

Filing date 29 January 2007

Wipo publication date 15 February 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/775 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

Event Publications

15 February 2007 Application Open to Public Inspection

  Published as AU-A-2007200352

15 February 2007 Complete Application Filed

30 August 2007 Section 223 Application Allowed

  Creighton University; Oscient Pharmaceuticals Corporation The time in which to comply wit a direction under Reg. 3.4(4) has been extended to 02 Jun 2007. Address for service in Australia - Blake Dawson Waldron Patent Services Level 39 101 Collins Street Melbourne VIC 3000

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007200353-Apparatus, and associated method, for providing inner-cell registration of access terminal in a radio communication system

2007200351-Counterflow injection mechanism having coaxial fuel-air passages